Caribou Biosciences saw the highest growth of 2.49% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Caribou Biosciences‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Caribou Biosciences has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 38% of filings. The United States(US), World Intellectual Property Organization(WIPO), Australia(AU), and China(CN) patent Office are among the top ten patent offices where Caribou Biosciences is filings its patents..
Regeneron Pharmaceuticals and Massachusetts Institute of Technology could be the strongest competitors for Caribou Biosciences
Patents related to genetically modified organism (GMO) and cell & gene therapy lead Caribou Biosciences's portfolio
Caribou Biosciences has the highest number of patents in genetically modified organism (GMO) followed by, cell & gene therapy and genomics. For genetically modified organism (GMO), nearly 33% of patents were filed and no patents were granted in Q2 2024.
Epstein–barr virus (hhv-4) infections related patents lead Caribou Biosciences portfolio followed by human immunodeficiency virus (hiv) infections (aids), and multiple myeloma (kahler disease)
Caribou Biosciences has highest number of patents in epstein–barr virus (hhv-4) infections followed by human immunodeficiency virus (hiv) infections (aids), multiple myeloma (kahler disease), melanoma.
For comprehensive analysis of Caribou Biosciences's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
